Saturday, July 20, 2019

Intravenous Vitamin C with Decitabine Results in Double the Complete Remissions of AML Compared to Decitabine Alone.

The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia.

Vitamin C is an immunotherapy via TET2.
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)